Number of the records: 1
HPMA copolymer mebendazole conjugate allows systemic administration and possesses antitumour activity in vivo
- 1.Studenovský, M., Rumlerová, A., Kovářová, J., Dvořáková, B., Sivák, L., Kostka, L., Berdár, D., Etrych, T., Kovář, M. HPMA copolymer mebendazole conjugate allows systemic administration and possesses antitumour activity in vivo. Pharmaceutics. 2022, 14(6), 1201. E-ISSN 1999-4923. Available: doi: 10.3390/pharmaceutics14061201.
Number of the records: 1